Pursuant to regulation 32 of SEBI (Listing Obligation and Disclosure Requirements, 2015, read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding submission ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences has informed BSE that the Statement of Deviation or Variation under SEBI Regulation 32 is not applicable to the company. This is because the company has not raised any funds through a public issue, rights issue, preferential issue, or qualified institutions placement. The letter, signed by Company Secretary Chaitra Arora, was filed on 12th February 2026 as a routine compliance confirmation. No financial details, fundraising activity, or material event is involved.
No impact on shareholders or stock price — this is a standard regulatory filing confirming the absence of recent fundraising, so there is nothing new for investors to act on.